Swiss company reduces its dependence on the high margin, but volatile, pharmaceuticals business by buying rival specialty chemicals group Source: FT.com - Pharmaceuticals
This site uses Cookies to dispense or record information with regards to your visit. By continuing to use this site you agree to the terms outlined in ourCookies used here:Privacy / Disclaimer,